Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This is a pilot study.
The aim of the investigators' study is to evaluate the effectiveness of nigella sativa seed
in the treatment of dyslipidemia.
Dyslipidemia is a common risk factor for cardiovascular disease, the leading cause for
morbidity and mortality among patients.
Nigella sativa is an easily available and acceptable remedy to treat dyslipidemia and at a
low cost.
It is expected that by scientifically determining the effectiveness of this intervention it
will lead to its widespread use.
This will provide a low cost alternative to treat dyslipidemia.